Here are Monday's biggest analyst calls: Nvidia, Apple, SpaceX, Dell, Deere, Broadcom, Costco, Redcat & more

Wall Street calls were broadly constructive, with multiple buy/overweight initiations and upgrades: Morgan Stanley initiated Attovia Therapeutics at Overweight with a $39 PT; UBS upgraded Kaiser Aluminum to Buy with a $184 PT; Evercore ISI initiated Lumentum at Outperform with a $1,100 target. In semis/AI infrastructure plays, JPMorgan reiterated AI beneficiaries including Broadcom, Nvidia and Marvell as Overweight, while Bank of America lifted Dell’s PT to $505 ahead of earnings. Overall, the updates skew positive but are mostly rating/target-driven rather than immediate earnings/news catalysts.

Analysis

The most actionable read-through is not the upgrades themselves, but the widening dispersion inside the AI capex complex. NVDA/AVGO remain the obvious core, but the better incremental upside over the next 1-3 months may sit in the picks-and-shovels names where revisions are still underappreciated: DELL for system mix/operating leverage and LITE for optical bottlenecks. If enterprise AI spend stays durable, the market should keep paying for throughput enablers rather than just the compute layer.

Apple looks like the cleanest hedge because the problem is not FX math; it is demand elasticity and mix risk. Local price increases can be absorbed mechanically, but if China unit volumes soften or premium-model mix slips, margin support from currency gets overwhelmed quickly. That creates a two-step downside: first on near-term iPhone checks, then on FY26 EPS and multiple compression if services alone cannot offset hardware weakness.

The cyclical calls on DE and KALU matter on a longer horizon, but they are not immediate catalysts. Deere is a 6-18 month expression on farm-income normalization and capex recovery; KALU is more vulnerable to policy and scrap-spread noise than to a clean end-market inflection. The small-cap biotech/defense names are mostly idiosyncratic optionality — worth watching for budget or data catalysts, but not something to force ahead of verification. Consensus may be underestimating how crowded the large-cap AI winners are and overestimating how quickly retail-facing hardware can reaccelerate from here.

Key Decisions for Investors

• Short AAPL via 2-3 month put spread or on strength; thesis breaks if China channel checks show sustained unit share gains or gross margin guide re-accelerates.
• Long DELL vs short QQQ or short AAPL as a relative-value pair for the next earnings cycle; best risk/reward if AI server demand and storage attach stay firm.
• Add to LITE on pullbacks as a higher-beta AI infrastructure beneficiary; use a 1-3 month horizon and cut if networking/optics order commentary softens.
• Accumulate DE on weakness for a 6-18 month macro recovery trade; invalidation is a renewed downcycle in crop incomes or weaker 2027 delivery expectations.
• Treat NVDA/AVGO as hold/overweight but prefer MRVL/LITE for new money; the market may already be paying up for the most obvious AI winners.